These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 16617302)

  • 1. Increased VEGF levels induced by anti-VEGF treatment are independent of tumor burden in colorectal carcinomas in mice.
    Schmitz V; Vilanueva H; Raskopf E; Hilbert T; Barajas M; Dzienisowicz C; Gorschlüter M; Strehl J; Rabe C; Sauerbruch T; Prieto J; Caselmann WH; Qian C
    Gene Ther; 2006 Aug; 13(16):1198-205. PubMed ID: 16617302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective angiostatic treatment in a murine metastatic and orthotopic hepatoma model.
    Raskopf E; Dzienisowicz C; Hilbert T; Rabe C; Leifeld L; Wernert N; Sauerbruch T; Prieto J; Qian C; Caselmann WH; Schmitz V
    Hepatology; 2005 Jun; 41(6):1233-40. PubMed ID: 15915456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference.
    Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM
    J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor KDR].
    Chen XL; Liu LC; Xu ZG; Li Z; Li RW; Gao RJ; Wang S; Zhang M; Guo H
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):578-82. PubMed ID: 19102933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lethality in an anti-angiogenic tumor gene therapy model upon constitutive but not inducible expression of the soluble vascular endothelial growth factor receptor 1.
    Sivanandam VG; Stephen SL; Hernandez-Alcoceba R; Alzuguren P; Zabala M; van Rooijen N; Qian C; Berger I; Gross ML; Prieto J; Kochanek S
    J Gene Med; 2008 Oct; 10(10):1083-91. PubMed ID: 18720430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma.
    Shiose S; Sakamoto T; Yoshikawa H; Hata Y; Kawano Y; Ishibashi T; Inomata H; Takayama K; Ueno H
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2395-403. PubMed ID: 10937546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice.
    He XW; Yu X; Liu T; Yu SY; Chen DJ
    Chin Med J (Engl); 2008 Mar; 121(5):439-44. PubMed ID: 18364118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach.
    Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX
    Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of inhabitation of VEGF expression with RNA interference on lung cancer therapy].
    Zhang Y; Gu ZP; Zhou YA; Wang YJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Apr; 25(4):341-3, 347. PubMed ID: 19351507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated delivery of a soluble form of the VEGF receptor Flk1 delays the growth of murine and human pancreatic adenocarcinoma in mice.
    Tseng JF; Farnebo FA; Kisker O; Becker CM; Kuo CJ; Folkman J; Mulligan RC
    Surgery; 2002 Nov; 132(5):857-65. PubMed ID: 12464871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF-targeted RNA interference suppresses angiogenesis and tumor growth of retinoblastoma.
    Jia RB; Zhang P; Zhou YX; Song X; Liu HY; Wang LZ; Luo M; Lu J; Ge SF; Fan XQ
    Ophthalmic Res; 2007; 39(2):108-15. PubMed ID: 17284938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrodynamics-based gene delivery of naked DNA encoding fetal liver kinase-1 gene effectively suppresses the growth of pre-existing tumors.
    Yazawa H; Murakami T; Li HM; Back T; Kurosaka K; Suzuki Y; Shorts L; Akiyama Y; Maruyama K; Parsoneault E; Wiltrout RH; Watanabe M
    Cancer Gene Ther; 2006 Nov; 13(11):993-1001. PubMed ID: 16763608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short hairpin RNA-expressing oncolytic adenovirus-mediated inhibition of IL-8: effects on antiangiogenesis and tumor growth inhibition.
    Yoo JY; Kim JH; Kim J; Huang JH; Zhang SN; Kang YA; Kim H; Yun CO
    Gene Ther; 2008 May; 15(9):635-51. PubMed ID: 18273054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
    Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
    Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longterm recombinant adeno-associated, virus-mediated, liver-generated expression of an angiogenesis inhibitor improves survival in mice with disseminated neuroblastoma.
    Streck CJ; Zhou J; Ng CY; Zhang Y; Nathwani AC; Davidoff AM
    J Am Coll Surg; 2004 Jul; 199(1):78-86. PubMed ID: 15217634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased plasma vascular endothelial growth factor (VEGF) as a surrogate marker for optimal therapeutic dosing of VEGF receptor-2 monoclonal antibodies.
    Bocci G; Man S; Green SK; Francia G; Ebos JM; du Manoir JM; Weinerman A; Emmenegger U; Ma L; Thorpe P; Davidoff A; Huber J; Hicklin DJ; Kerbel RS
    Cancer Res; 2004 Sep; 64(18):6616-25. PubMed ID: 15374976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.
    Guan H; Zhou Z; Wang H; Jia SF; Liu W; Kleinerman ES
    Clin Cancer Res; 2005 Apr; 11(7):2662-9. PubMed ID: 15814647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent delivery of GM-CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors.
    Tai KF; Chen PJ; Chen DS; Hwang LH
    J Gene Med; 2003 May; 5(5):386-98. PubMed ID: 12731087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
    Ebos JM; Lee CR; Bogdanovic E; Alami J; Van Slyke P; Francia G; Xu P; Mutsaers AJ; Dumont DJ; Kerbel RS
    Cancer Res; 2008 Jan; 68(2):521-9. PubMed ID: 18199548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vector-based RNAi approach to isoform-specific downregulation of vascular endothelial growth factor (VEGF)165 expression in human leukemia cells.
    Shen HL; Xu W; Wu ZY; Zhou LL; Qin RJ; Tang HR
    Leuk Res; 2007 Apr; 31(4):515-21. PubMed ID: 17034851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.